Verana Health has announced significant enhancements to its Site Explorer application, marking a major advancement in promoting diversity within clinical trials. The digital health company's latest update enables precise identification of clinical practices based on their patient demographics, particularly focusing on underrepresented racial and ethnic groups.
The enhanced platform leverages an extensive database of electronic health records from up to 80 million de-identified patients, collected through Verana Health's exclusive partnership with the American Academy of Ophthalmology IRIS® Registry - the largest specialty society clinical data registry in medicine. This vast data repository allows researchers and trial sponsors to gain unprecedented insights into patient cohort representation at individual trial sites.
Enhanced Capabilities for Diverse Trial Design
The upgraded Site Explorer provides users with sophisticated tools to analyze and set enrollment targets across various demographic subgroups, including age, sex, race, and ethnicity. This granular level of detail extends to indication-specific data, enabling more precise and intentional trial planning.
"Clinical trials are the cornerstone of medicine and healthcare," stated Sujay Jadhav, CEO of Verana Health. "Advancing treatments, developing new drugs and improving patient outcomes relies on robust data and strong science. One key pathway for ensuring sound clinical trials is through fully representative clinical trials that enhance the body of evidence for a treatment or a patient population."
Streamlined Protocol Optimization
Site Explorer's user-friendly interface eliminates the need for coding expertise, featuring curated codelists that simplify the search process for diagnoses and procedures. The tool provides comprehensive visibility into prospective study sites, potential referral sources, and de-identified patient populations, enabling more efficient and effective trial site selection.
Impact on Clinical Research
The platform's enhancement represents a significant step forward in addressing the historical underrepresentation of certain demographic groups in clinical trials. By providing sponsors and Contract Research Organizations (CROs) with detailed demographic insights, Site Explorer supports the industry's commitment to ensuring treatment safety and efficacy across diverse patient populations.
Drawing from a network of more than 20,000 clinicians, Verana Health's platform combines advanced technology with deep expertise to deliver actionable insights that can transform the clinical trial landscape. This data-driven approach promises to accelerate the development of more inclusive and representative clinical studies, ultimately leading to better-informed treatment decisions for all patient populations.
